Dyne Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYN and other ETFs, options, and stocks.

About DYN

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. 

CEO
John G. Cox
CEOJohn G. Cox
Employees
191
Employees191
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2017
Founded2017
Employees
191
Employees191

DYN Key Statistics

Market cap
1.26B
Market cap1.26B
Price-Earnings ratio
-3.30
Price-Earnings ratio-3.30
Dividend yield
—
Dividend yield—
Average volume
2.35M
Average volume2.35M
High today
$11.22
High today$11.22
Low today
$10.77
Low today$10.77
Open price
$10.85
Open price$10.85
Volume
1.57M
Volume1.57M
52 Week high
$47.45
52 Week high$47.45
52 Week low
$6.36
52 Week low$6.36

Analyst ratings

93%

of 14 ratings
Buy
92.9%
Hold
7.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.